Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2021 | 09-2020 | 03-2020 | 09-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,862 | 27,513 | 1,895 | 3,704 | 3,314 |
| Other current assets | 2,302 | 839 | 2,220 | 1,426 | 2,247 |
| TOTAL | $42,164 | $29,468 | $4,115 | $5,807 | $5,561 |
| Non-Current Assets | |||||
| PPE Net | 3,870 | 3,709 | 3,995 | 134 | 175 |
| Intangibles | 408 | 411 | 415 | 417 | 421 |
| TOTAL | $4,278 | $4,120 | $4,410 | $551 | $596 |
| Total Assets | $46,442 | $33,588 | $8,525 | $6,358 | $6,157 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 0 | 468 | N/A |
| Accounts payable and accrued liabilities | 3,385 | 1,845 | 2,206 | 1,490 | 2,144 |
| TOTAL | $9,658 | $10,934 | $2,844 | $4,867 | $2,549 |
| Non-Current Liabilities | |||||
| Long Term Debt | 12,526 | 16,758 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 184 |
| TOTAL | $15,467 | $19,967 | $3,466 | $0 | $184 |
| Total Liabilities | $25,125 | $30,901 | $6,310 | $4,867 | $2,733 |
| Shareholders' Equity | |||||
| Common Shares | 2,739 | 1,952 | 1,900 | 1,265 | 1,265 |
| Retained earnings | -54,928 | -42,213 | -37,342 | -34,142 | -32,171 |
| Other shareholders' equity | 7,407 | 5,763 | 1,009 | 1,104 | 1,066 |
| TOTAL | $21,317 | $2,687 | $2,215 | $1,491 | $3,424 |
| Total Liabilities And Equity | $46,442 | $33,588 | $8,525 | $6,358 | $6,157 |